Anthony LaPlaca - Mar 11, 2022 Form 4 Insider Report for INVACARE CORP (IVC)

Role
Sr. VP and General Counsel
Signature
/s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission
Stock symbol
IVC
Transactions as of
Mar 11, 2022
Transactions value $
$14,915
Form type
4
Date filed
3/14/2022, 04:42 PM
Previous filing
Jul 16, 2021
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IVC Common Shares Purchase $14.9K +10K +11.31% $1.49* 98.4K Mar 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVC Employee Stock Option (Right to Buy) 71.9K Mar 11, 2022 Common Shares 71.9K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.475 to $1.51, inclusive. The reporting person undertakes to provide to Invacare Corporation, any security holder of Invacare Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2 No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
F3 The reporting person holds previously reported options to buy 71,933 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between August 14, 2012 and March 16, 2017, at exercise prices between $12.15 to $14.49 per share, will expire between August 14, 2022 and March 16, 2027, and became exercisable between September 30, 2013 and February 19, 2020. The balance reflects the expiration of options to buy 11,200 Common Shares on September 2, 2021.